The product basket of PMBJP comprises 1,451 drugs and 240 surgical instruments. *The PLI scheme for pharmaceuticals is being implemented with a total outlay of the Rs. 15,000 crore (US$ 2.04 billion) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A Nidhi company is a non-banking financial company. The core business of Nidhi companies is borrowing and lending money between their members. Know more about the Nidhi Company Registration Insertion ...

The purpose of Mahila Udyam Nidhi is to help women entrepreneurs meeting equity funds requirement will setting up a new business. In case of a soft loan, only service charge @ 1% p.a. is payable, ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $468.09, demonstrating a +0.94% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.38% gain on the ...

Stifel raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $494 from $490 and keeps a Hold rating on the shares. With shares up 14% year-to-date, the stock has outperformed ...

Vertex Pharmaceuticals (Vertex) is a biotechnology company that discovers, develops and commercializes transformative drugs for the treatment of serious and life-threatening diseases. The company’s ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The drug candidate is administered through oral route. It acts by targeting APO-L1 function. Vertex Pharmaceuticals (Vertex) is a biotechnology company that discovers, develops and commercializes ...

Vertex Pharmaceuticals (VRTX) closed at $469.29 in the latest trading session, marking a -0.99% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.3%.